Savara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Stock Information for Savara Inc.

Loading

Please wait while we load your information from QuoteMedia.